Max Kros

Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma

Nataliya Zhukova, Vijay Ramaswamy, Marc Remke et al. · Journal of Clinical Oncology · 2013 · 488 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir

Peter Sillevis Smitt, M.J. Driesse, John G. Wolbers et al. · Molecular Therapy · 2003 · 100 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Molecular subtypes of glioma identified by genome‐wide methylation profiling

Nanne K. Kloosterhof, Johan J. de Rooi, Max Kros et al. · Genes Chromosomes and Cancer · 2013 · 34 citations

Medicine, Molecular Biology, Oncology +17

Dissociation between the Effects of Somatostatin (SS) and Octapeptide SS-Analogs on Hormone Release in a Small Subgroup of Pituitary- and Islet Cell Tumors

Leo J. Hofland, Wouter W. de Herder, Heleen Visser-Wisselaar et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 19 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Cardiac magnetic resonance imaging features prognostic information in patients with suspected myocardial infarction with non-obstructed coronary arteries

Tilman Emrich, Max Kros, U. Joseph Schoepf et al. · International Journal of Cardiology · 2020 · 16 citations

Medicine, Cardiology, Radiology +17